FPCPP, A Division of CFHC

Family Planning Cooperative Purchasing Program

A non-profit purchasing collaborative for health care & community organizations

January 17, 2012

An Important Drug Recall - LO/OVRAL-28 and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mg Tablets

Following is a Pfizer generated document we received on Friday, January 13, 2012:

 

Pfizer Inc. is recalling multiple lots of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mgTablets manufactured and packaged by Pfizer, and distributed and commercialized by Akrimax Pharmaceuticals, LLC (see below for lot numbers and expiration dates).  Please note that these products are labeled with Akrimax labeling.  Pfizer Inc. voluntarily initiated this recall when it was determined that some blister packs may contain an inexact count of placebo or active ingredient tablets.  Please note that use of this product is not likely to cause adverse health consequences.

 

FEDERAL REGULATIONS REQUIRE THAT YOU RESPOND TO THIS RECALL, EVEN IF YOU DO NOT HAVE THE RECALLED PRODUCT. TO RESPOND, PLEASE CONTACT STERICYCLE INC. AT 1(800)-805-3093 WITHIN FIVE (5) BUSINESS DAYS.

 

The recall of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03 mg Tablets is being conducted to the retail level.

 

Records indicate that you may have received shipment of affected lots between January 2011 and December 2011.  Please check your stock immediately against the table below.  If you have any of the affected products in your inventory, please stop distribution and promptly return to Stericycle Inc. 2670 Executive Drive, Suite A Indianapolis, IN 46241: Attn: Event 2568.  Please contact Stericycle Inc. at (800) 805-3093 if you require the pre-paid UPS labels.  If you have any medical inquiries regarding these products, please contact Akrimax Medical Information at 1(877)509-3935 (8 AM to 7 PM Mon-Fri CST).

 

If you have further distributed the lots to the retail level, please conduct a sub-recall and communicate this recall information to those accounts immediately.  Please request that they immediately cease distribution of the affected lots and promptly return the product directly to the above address.  If they have inventory of the affected product, they can contact Stericycle Inc. at (800) 805-3093 to obtain pre-paid shipping labels for product return.  Further authorization is not required for product return.  Reimbursement for the returned product will be made by credit memorandum.  If you have any questions regarding the reimbursement, please contact your Akrimax Customer Service Representative at 1(877) 509-3935 (8 AM to 7 PM Mon-Fri CST).

 

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.  We appreciate your immediate attention and cooperation to this matter.

 

LO/OVRAL® - 28 

LOT#         Expiration Date

E15678        8/31/2013

E15679        8/31/2013

E15686        8/31/2013

   E15687        1/31/2014   

E15690        1/31/2014

E15698        1/31/2014

E15700        2/28/2014

E80434        7/31/2013

E80438        8/31/2013

F36908        2/28/2014

F36909        2/28/2014

F43915        3/31/2014

F43926        3/31/2014

F43927        3/31/2014

 

NORGESTREL 0.3MG/ETHINYL ESTRADIOL 0.03 MG

LOT#         Expiration Date

E15677        8/31/2013

E15704        1/31/2014

E15706        1/31/2014

E80440        8/31/2013

F16388        1/31/2014

F16390        2/28/2014

F22132        2/28/2014

F31330        2/28/2014

F36911        3/31/2014

F36913        3/31/2014

F43924        3/31/2014

F43925        3/31/2014

F43934        3/31/2014

F53238        3/31/2014

January 17, 2012 in Contraception , Cooperative Updates , Health Care , Oral Contraceptives , Pharmaceutical Products , Pharmaceuticals , Sales , Women’s Health | Permalink | TrackBack (0)

October 19, 2011

Daily-Vite from R&S Northeast

Daily-Vite from R&S Northeast

Daily Multiple Vitamin Supplement

 

Save 10% off your first purchase of 12 Bottles of Daily-Vites.

Folic Acid is a B vitamin that helps a baby's neural tube grow healthy during pregnancy.  The neural tube will become a baby's brain and spinal cord.  But if the neural tube doesn't close the way it should, it can cause a very serious birth defect called a neural tube defect (NTD).

 

  • Folic Acid helps prevent certain brain defects.
  • Folic acid works if taken before and during early pregnancy.
  • Take a daily multivitamin with 400 micrograms of folic acid.

 

 

R&S DailyViteRS

Please contact your R&S Sales Representative  for pricing.

Pennsylvania (800) 262-7770

Ohio (866) 994-7472

Kentucky (866) 228-9758

 

Be sure to mention that you are a member of the Cooperative Purchasing Program!



October 19, 2011 in Coupons , Health Care , Pharmaceutical Products , Pharmaceuticals , R&S Northeast , Sales , Teen Pregnancy , Vendors , Women’s Health | Permalink | TrackBack (0)

June 09, 2011

Special Promotion from GYN Disposables

Right now, GYN Disposables is offering Co-Op Members a special offer

Buy 5 UltraLite Kits, Get 1 FREE!

Call 888.377.2203 or visit www.gyndisposables.com

GYNPromoJune2011 

June 9, 2011 in Cancer , Cooperative Updates , Coupons , Health Care , Sales , Vendors , Women’s Health | Permalink | TrackBack (0)

April 13, 2009

Family Planning Services Exemplify Prevention-Based Health Reform Principles, Guttmacher Policy Review Says

Public Release Date: 26-March-2009

Summary of "Family Planning and Health Care Reform: The Benefits and Challenges of Prioritizing Prevention," Gold, Guttmacher Policy Review, Winter 2009.

President Obama's administration and Congress have indicated an interest in pursuing health care reform that prioritizes prevention, and "family planning exemplifies both the benefits of prevention and the issues inherent in trying to remake the current health financing system to work for prevention," Rachel Benson Gold of the Guttmacher Institute writes in a Guttmacher Policy Review article.

Continue reading "Family Planning Services Exemplify Prevention-Based Health Reform Principles, Guttmacher Policy Review Says "

April 13, 2009 in Health Care , Medical Access , Public Policy , Women’s Health | Permalink | TrackBack (0)

December 09, 2008

Washington Post Magazine Examines Medical Students' Decision Whether To Become Abortion Providers

Public Release Date: 24-November-2008

The Washington Post Magazine on Sunday examined challenges medical students face when considering whether to become abortion providers. According to the Post Magazine, the number of abortion providers in the U.S. is declining, and "unless a new generation [takes] their place, the right to abortion might be rendered meaningless." The Post Magazine profiled Lesley Wojcik -- a medical student at the University of Maryland School of Medicine -- who was considering becoming an abortion provider but ultimately decided to forgo her plans.

Continue reading "Washington Post Magazine Examines Medical Students' Decision Whether To Become Abortion Providers"

December 9, 2008 in Abortion , Health Care , Women’s Health | Permalink | TrackBack (0)

October 27, 2008

Project Highlights Changing Face of Nurses in Films Over the Last 100 Years

Public Release Date: 12-October-2008 

An extensive study of how the nursing profession has been portrayed in films over the last century has shown that unflattering stereotypes are becoming less common and nurses are now being portrayed in a more positive light.

Continue reading "Project Highlights Changing Face of Nurses in Films Over the Last 100 Years "

October 27, 2008 in Health Care , News | Permalink | TrackBack (0)

May 22, 2008

For Clinicians: Updated Sexually Transmitted Infection Screening and Treatment

Public Release Date: 14-May-2008

Sexually transmitted infections (STIs) have been in the news recently as new epidemiologic trends emerge:

CFHC has collaborated with staff at the California STD Branch at the California Department of Public Health to highlight important strategies for preventing and treating STIs as recommended by the CDC in their STD Treatment Guidelines.

Recommendations for HPV vaccination and changes in the management of abnormal Pap tests are also noted. Providers are invited to download the 2-page California STD Treatment Summary Table (PDF) and refer to the California STD Clinical Guidelines for further information on the latest recommendations for screening, testing, treatment, and partner management for STIs in California.

click here to continue

Written by: Ina Park M.D., M.S., Clinical STD Fellow, California Department of Public Health-STD Control Branch

Posted thanks to News & Views, a quarterly publication of the California Family Health Council, Inc.

May 22, 2008 in Health Care , Public Policy , STD , Women’s Health | Permalink | TrackBack (0)

August 27, 2007

Literacy Linked to Survival in Medicare Patients

Public Release Date: 24-July-2007

CHICAGO -- Medicare patients who couldn't read a physician's instructions, or who didn't understand what they read had a higher mortality rate than patients with adequate reading skills.

After adjusting for demographics, socioeconomic status, disability, and chronic conditions, patients with inadequate health literacy were 52% more likely to die during an average of 67.8 months of follow-up (P<0.001), according to a study reported in the July 23 issue of Archives of Internal Medicine.

Continue reading "Literacy Linked to Survival in Medicare Patients"

August 27, 2007 in Educational , Health Care , Medical Access , News | Permalink | TrackBack (0)

May 11, 2007

AHA Forum: Healthy Workplace, Healthy Workers

Public Release Date: 10-May-2007

WASHINGTON, May 10 -- An employee health program incorporating a fitness center, health education, and incentives improved workers' cardiovascular health and workplace safety, investigators reported here.

Employees who availed themselves of those services improved blood pressure control by 9% and diabetes control by 15%, found Sharon A. Clark, D.H.Sc., of JEA, the municipal utility company in Jacksonville, Fla., and colleagues.

Continue reading "AHA Forum: Healthy Workplace, Healthy Workers"

May 11, 2007 in Health Care , Medical Access , News , Women’s Health | Permalink | TrackBack (0)

May 10, 2007

ACOG: Plan B Availability Varies from State to State

Public Release Date: 9-May-2007

SAN DIEGO -- Those who battled the FDA for non-prescription status of Plan B (levonorgestrel) apparently won only half the struggle. Prescription or not, Plan B can be hard to get.

A survey of Plan B availability in three major cities found that state laws can override the ease of access to the emergency contraception agent, whether by prescription or "under-the-counter" sales.

Continue reading "ACOG: Plan B Availability Varies from State to State"

May 10, 2007 in Contraception , Contraceptives , Health Care , Medical Access , News , Oral Contraceptives , Pharmaceuticals , Public Policy , Women’s Health | Permalink | TrackBack (0)